Related Experiment Video
Updated: Jun 15, 2026
11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
MARCH-I: a new regulator of dendritic cell function.
Satoshi Ishido1, Yohei Matsuki, Eiji Goto
1Laboratory for Infectious Immunity, RIKEN Research Center for Allergy and Immunology, Yokohama, Kanagawa, 230-0045, Japan. ishido@rcai.riken.jp
Molecules and Cells
|March 10, 2010
Summary
The study reviews how MARCH-I ubiquitination regulates MHC class II (MHC II) expression. It highlights the need to understand MARCH-I
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- MHC class II (MHC II) expression is regulated by ubiquitination of its beta chain.
- MARCH-I, an E3 ubiquitin ligase, plays a critical role in this ubiquitination process.
Purpose of the Study:
- To summarize recent findings on MARCH-I-mediated MHC II ubiquitination.
- To discuss the in vivo significance of MARCH-I in MHC II regulation.
- To address challenges in studying MARCH-I-mediated MHC II ubiquitination.
Main Methods:
- Literature review of existing studies on MARCH-I and MHC II.
- Analysis of ubiquitination pathways.
- Discussion of in vivo models and experimental challenges.
Main Results:
- MARCH-I is essential for ubiquitination of the MHC II beta chain.
- The in vivo role of MARCH-I in MHC II regulation requires further investigation.
- Current research focuses on understanding the precise mechanisms and physiological relevance.
Conclusions:
- MARCH-I is a key regulator of MHC II ubiquitination.
- Further research is needed to elucidate the in vivo functions of MARCH-I.
- Overcoming experimental hurdles is crucial for advancing this field.
